These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7187367

  • 1. [Effect of the cardiac glycosides lanatoside C and strophanthin K on left on left ventricular function in patients with mitral stenosis].
    Dubiel JP, Kolasińska-Kloch W.
    Folia Med Cracov; ; 24(1-2):25-39. PubMed ID: 7187367
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of strophantin on right ventricular function in patients with mitral stenosis (author's transl)].
    Dubiel JP, Kolasinska-Kloch W.
    Przegl Lek; 1981; 38(2):283-8. PubMed ID: 7244285
    [No Abstract] [Full Text] [Related]

  • 3. Comparative study of the cardiac and peripheral vascular effects of strophantin K and lanatoside C in coronary heart disease.
    Matos L, Békés M, Polák G, Rausch J, Török E.
    Eur J Clin Pharmacol; 1975 Oct 10; 9(1):27-37. PubMed ID: 1233250
    [Abstract] [Full Text] [Related]

  • 4. [DIFFERENTIATED USE OF CARDIAC GLYCOSIDES].
    BAYER O.
    Hippokrates; 1964 Feb 29; 35():140-3. PubMed ID: 14152489
    [No Abstract] [Full Text] [Related]

  • 5. Effect of lanatoside C on right ventricular function and pulmonary circulation in patients with mitral stenosis.
    Dubiel JP, Kolasińska-Kloch W.
    Acta Med Pol; 1981 Feb 29; 22(1):59-74. PubMed ID: 7270247
    [No Abstract] [Full Text] [Related]

  • 6. [The use of proscillaridin A in the therapy of cardiac insufficiency in the aged].
    Castrucci D, Morini PL.
    Minerva Med; 1967 Nov 14; 58(91):3917-21. PubMed ID: 6081708
    [No Abstract] [Full Text] [Related]

  • 7. [Selection of cardiac glycosides for acute usage].
    Beermann B, Lundman T.
    Lakartidningen; 1974 Mar 06; 71(10):919. PubMed ID: 4826126
    [No Abstract] [Full Text] [Related]

  • 8. [Dynamics of the total left ventricular systole under the influence of cardiac glycosides with particular reference to proscillaridin A].
    Adamska-Dyniewska H.
    Pol Tyg Lek; 1969 Oct 06; 24(40):1523-5. PubMed ID: 5365667
    [No Abstract] [Full Text] [Related]

  • 9. [Quantitative studies on the therapeutic range of cardiac glycosides].
    Diederen W, Kadatz R.
    Arztl Forsch; 1970 May 10; 24(5):149-55. PubMed ID: 5538016
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of strophanthin on the duration of phases of the heart cycle in patients with heart defects and circulatory disorders. (Based on electrokymographic data)].
    Vebrova NN, Grugorian EA.
    Klin Med (Mosk); 1966 Jan 10; 44(1):72-8. PubMed ID: 5984429
    [No Abstract] [Full Text] [Related]

  • 11. [Practical use of cardiac glycosides].
    Ignat'ev MV.
    Voen Med Zh; 1976 Sep 10; (9):78-80. PubMed ID: 1034366
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical studies with a new cardiac glycoside proscillaridine A (Sandoscill)].
    Hansel J.
    Med Klin; 1968 Jun 07; 63(23):919-22. PubMed ID: 4875202
    [No Abstract] [Full Text] [Related]

  • 13. [On the preoperative and postoperative cardiac glycoside therapy].
    Endte K, Köle W, Müller V, Werner H.
    Wien Med Wochenschr; 1968 Mar 30; 118(13):276-80. PubMed ID: 5672069
    [No Abstract] [Full Text] [Related]

  • 14. [Clinico-functional correlations of left atrial myocardial excursions in patients with mitral valve defects].
    Iakovlev VF, Kurdov MK, Shevelev II, Solovova LE.
    Kardiologiia; 1992 Apr 30; 32(4):51-4. PubMed ID: 1405238
    [Abstract] [Full Text] [Related]

  • 15. [Positive inotropic effect of digitalis on the left ventricular systolic time interval in patients with primary dilated cardiomyopathy observed during increased heart ventricle load].
    Dubiel JP, Cibor E.
    Przegl Lek; 1986 Apr 30; 43(6):433-8. PubMed ID: 3775049
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of cardiac glycosides and ATP on the indices of myocardial bioelectrical activity and contractile function in cardiovascular insufficiency].
    Kovshar' FV, Kit SM, Arzhanykh NG, Babenko NA, Boĭchuk RV.
    Farm Zh; 1975 Apr 30; (5):55-7. PubMed ID: 773674
    [No Abstract] [Full Text] [Related]

  • 17. [Pharmacological and clinical considerations on the association ATP-cardiac glycosides (lanatoside C, strophanthin) in the treatment of arteriosclerotic heart disease].
    DE CAROLIS GD.
    Atti Soc Ital Cardiol; 1959 Apr 30; 21(2)():Comunicazioni 115-7. PubMed ID: 13814704
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of cardiac emergencies with K-strophanthoside and lanatoside C.
    RITOTA MC.
    J Med Soc N J; 1951 Aug 30; 48(8):354-56. PubMed ID: 14861601
    [No Abstract] [Full Text] [Related]

  • 19. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H, Kwit NT, Shane SJ, Dayrit C.
    J Clin Pharmacol J New Drugs; 1969 Aug 30; 9(3):148-54. PubMed ID: 5255179
    [No Abstract] [Full Text] [Related]

  • 20. [On the problem of the method of prolonged use of cardiac glycosides in patients with mitral defects and chronic circulatory insufficiency].
    Kats GL.
    Sov Med; 1967 Apr 30; 30(4):79-83. PubMed ID: 5608582
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.